
New Launch30 March 2026 at 12:21 pm
Alkem Laboratories Establishes Wholly Owned Subsidiary as Scientific Office in Dubai Healthcare City, UAE
AI Summary
Alkem Laboratories Ltd. has incorporated a Wholly Owned Subsidiary (WOS) named 'Alkem Pharmaceuticals Scientific Office FZ LLC' in Dubai Healthcare City, UAE. The WOS, with an authorized and subscribed capital of AED 3,670,000 divided into 3,670 Equity Shares of AED 1,000 each, has been set up to undertake the activities of manufacturing products and obtaining product registrations, except trading activities. The subsidiary is a related party of Alkem Laboratories Limited, and related party transactions, if any, will be done at 'arm’s length'. The subsidiary's operations are currently delayed due to ongoing regional conflicts affecting related approvals from UAE’s Ministry of Health and Prevention.
Key Highlights
- Alkem Laboratories Ltd. has incorporated a Wholly Owned Subsidiary (WOS) named 'Alkem Pharmaceuticals Scientific Office FZ LLC' in Dubai Healthcare City, UAE
- The WOS has an authorized and subscribed capital of AED 3,670,000 divided into 3,670 Equity Shares of AED 1,000 each
- The WOS will undertake the activities of manufacturing products and obtaining product registrations, except trading activities
- The WOS is a related party of Alkem Laboratories Limited and related party transactions, if any, will be done at 'arm’s length'
- Operations are currently delayed due to ongoing regional conflicts affecting related approvals from UAE’s Ministry of Health and Prevention
ALKEMPharmaceuticals
Alkem Laboratories LtdPrice Impact